Jiangxi Yeli Technology Group Co., Ltd., established in 2011 and located in Jiahai Industrial Park, National High and New Technology Development Zone, Nanchang City, is a company specializing in the diagnosis of two major diseases, namely, microbial infections and autoimmune diseases. It has built a technical platform based on liquid based thin layer production and microbial targeted fluorescence staining, as well as a molecular technology platform based on fluorescence quantitative PCR technology, It has formed two major product lines for microbiological morphology diagnosis and HLA genotyping diagnosis of autoimmune related diseases, and is a high-tech enterprise integrating research and development, production, sales, and third-party medical services. It is also approved by the Jiangxi Provincial Department of Science and Technology as a "high-tech small and medium-sized enterprise".
Currently, there are more than 200 employees
Obtained 3 patents in the product field
44 intellectual property rights and patents have been declared
Yeli Group is a limited liability enterprise integrating the research, development, production, and sales of medical consumables, diagnostic reagents, and supporting equipment, with over 200 employees. Its subsidiaries include six biomedical technology companies, including Jiangxi Yeli Medical Device Co., Ltd., Jiangxi Dongsen Technology Development Co., Ltd., Nanchang Zhongshen Medical Device Co., Ltd., Nanchang Yeli Medical Laboratory Co., Ltd., Jiangxi Changda Yeli Biotechnology Co., Ltd., and Nanchang Zhenxing Biotechnology Co., Ltd. As a technological innovation driven enterprise, Jiangxi Yeli Medical Device Co., Ltd. has currently applied for multiple intellectual property rights, with 44 patents declared, of which 12 have been certified.
In the field of microbial infection, we have pioneered the development of liquid based fluorescent fungus detection technology, launched a series of products such as "true" sputum fungus detection kit, "true" alveolar lavage fluid detection kit, and "true" vaginal secretion detection kit, and obtained 30 patents.
On the molecular technology platform of fluorescence quantitative PCR technology, we have many products, including HLA-B27 genotyping detection kit, HLA-DR1/4/10 gene detection kit, HLA-B5 gene detection kit, HLA-CW6 gene detection kit, HLA-DR3, B8 gene detection kit, and so on.
The company implements a management model and system that is people-oriented and constantly innovative, "in order to make every life ultimately brilliant", and shoulders the corporate mission of "being healthy due to focus, and being more focused for health.". Through continuous product innovation, business innovation, and service innovation, we can accumulate comparative advantages and solve customers' difficulties, doubts, and challenges in a specific field. Create a core culture of "one home, one school, one flag, and one seed", and strive to achieve the ideal of "being Huawei in the medical industry".